肺癌患者-话题@MedSci

#肺癌患者#

303篇内容 | 5552人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990691, encodeId=176919906917d, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet Oncol：满足 vs 不满足USPSTF筛查标准的肺癌患者，5年生存率相似, objectType=article, longId=174580, objectId=87fc1e4580c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87fc1e4580c3, replyNumber=0, likeNumber=59, createdTime=2020-03-18, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87fc1e4580c3, moduleTitle=Lancet Oncol：满足 vs 不满足USPSTF筛查标准的肺癌患者，5年生存率相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87fc1e4580c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990668, encodeId=14bd1990668a2, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后, objectType=article, longId=154705, objectId=7bee154e0525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bee154e0525, replyNumber=0, likeNumber=72, createdTime=2019-09-02, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bee154e0525, moduleTitle=JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bee154e0525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990664, encodeId=67d61990664a5, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=PLos One：肺癌患者肺泡巨噬细胞中NLRP3/Caspase-1炎症小体的激活降低, objectType=article, longId=152062, objectId=1115152062dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1115152062dc, replyNumber=0, likeNumber=61, createdTime=2019-09-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1115152062dc, moduleTitle=PLos One：肺癌患者肺泡巨噬细胞中NLRP3/Caspase-1炎症小体的激活降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1115152062dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990666, encodeId=51ec19906669f, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率, objectType=article, longId=153840, objectId=5663153840a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5663153840a9, replyNumber=0, likeNumber=74, createdTime=2019-06-14, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5663153840a9, moduleTitle=MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5663153840a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990692, encodeId=2d3519906927d, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=英国NICE推荐将辉瑞的Vizimpro用于治疗EGFR阳性的非小细胞肺癌患者, objectType=article, longId=174933, objectId=51dc1e4933dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51dc1e4933dc, replyNumber=0, likeNumber=91, createdTime=2019-12-03, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51dc1e4933dc, moduleTitle=英国NICE推荐将辉瑞的Vizimpro用于治疗EGFR阳性的非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51dc1e4933dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990677, encodeId=e30419906e7bf, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=AACR：PD-1单抗keytruda在晚期小细胞肺癌患者中显示出抗肿瘤潜力, objectType=article, longId=163662, objectId=fc6a1636624d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc6a1636624d, replyNumber=0, likeNumber=144, createdTime=2019-08-06, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc6a1636624d, moduleTitle=AACR：PD-1单抗keytruda在晚期小细胞肺癌患者中显示出抗肿瘤潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc6a1636624d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990695, encodeId=7fe7199069592, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet Oncol：Nivolumab治疗与晚期非小细胞肺癌患者4年生存期, objectType=article, longId=177733, objectId=5c4f1e77336b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c4f1e77336b, replyNumber=0, likeNumber=94, createdTime=2020-03-05, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c4f1e77336b, moduleTitle=Lancet Oncol：Nivolumab治疗与晚期非小细胞肺癌患者4年生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c4f1e77336b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990660, encodeId=4c5819906604f, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=ANN ONCOL：ALK FISH阳性率与ALK阳性非小细胞肺癌患者接受克唑替尼治疗有效性之间的关系, objectType=article, longId=150025, objectId=d10815002592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10815002592, replyNumber=0, likeNumber=55, createdTime=2018-12-03, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10815002592, moduleTitle=ANN ONCOL：ALK FISH阳性率与ALK阳性非小细胞肺癌患者接受克唑替尼治疗有效性之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d10815002592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990689, encodeId=d18a19906899d, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理, objectType=article, longId=168422, objectId=323a16842219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=323a16842219, replyNumber=0, likeNumber=22, createdTime=2019-12-20, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=323a16842219, moduleTitle=2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=323a16842219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990679, encodeId=444419906e901, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=真实世界数据：支持阿法替尼用于老年晚期肺癌患者, objectType=article, longId=164174, objectId=b3091641e40b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3091641e40b, replyNumber=0, likeNumber=81, createdTime=2019-04-15, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3091641e40b, moduleTitle=真实世界数据：支持阿法替尼用于老年晚期肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3091641e40b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990662, encodeId=39b7199066227, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Chest：肺癌患者的咳嗽：特征和临床关联的纵向观察性研究, objectType=article, longId=151095, objectId=4d5c15109568, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d5c15109568, replyNumber=0, likeNumber=93, createdTime=2019-02-03, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d5c15109568, moduleTitle=Chest：肺癌患者的咳嗽：特征和临床关联的纵向观察性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d5c15109568)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990669, encodeId=f47919906690b, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=创新靶向药医保报销落地晚期肺癌患者的福音？, objectType=article, longId=155363, objectId=4e6e155363fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e6e155363fd, replyNumber=0, likeNumber=94, createdTime=2019-03-15, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e6e155363fd, moduleTitle=创新靶向药医保报销落地晚期肺癌患者的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e6e155363fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990683, encodeId=263c1990683a3, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Thorax：不能手术肺癌患者的多学科家庭康复治疗, objectType=article, longId=165374, objectId=35d21653e4bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35d21653e4bb, replyNumber=0, likeNumber=74, createdTime=2019-09-01, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35d21653e4bb, moduleTitle=Thorax：不能手术肺癌患者的多学科家庭康复治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35d21653e4bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990682, encodeId=cd361990682f4, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=肺癌患者半年后PET/CT复查，发现……, objectType=article, longId=165081, objectId=af6c16508122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af6c16508122, replyNumber=0, likeNumber=77, createdTime=2019-06-28, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af6c16508122, moduleTitle=肺癌患者半年后PET/CT复查，发现……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af6c16508122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990671, encodeId=2a8019906e179, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=PLos One：老年肺癌患者生存率预测G8筛查工具的前瞻性评估, objectType=article, longId=158526, objectId=73951585264f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73951585264f, replyNumber=0, likeNumber=139, createdTime=2019-06-08, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73951585264f, moduleTitle=PLos One：老年肺癌患者生存率预测G8筛查工具的前瞻性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73951585264f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990673, encodeId=ab5419906e3ac, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JTO：淋巴细胞浸润、PD-L1、吸烟史之间是何种微妙关系，它们如何影响未曾接受免疫抑制剂治疗的非小细胞肺癌患者的预后？, objectType=article, longId=159657, objectId=718f15965eed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=718f15965eed, replyNumber=0, likeNumber=62, createdTime=2019-07-13, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=718f15965eed, moduleTitle=JTO：淋巴细胞浸润、PD-L1、吸烟史之间是何种微妙关系，它们如何影响未曾接受免疫抑制剂治疗的非小细胞肺癌患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=718f15965eed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990663, encodeId=3c731990663e6, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害, objectType=article, longId=151992, objectId=4ba115199244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba115199244, replyNumber=0, likeNumber=63, createdTime=2019-10-09, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba115199244, moduleTitle=Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ba115199244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990672, encodeId=358c19906e25f, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素, objectType=article, longId=159074, objectId=2e171590e4ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e171590e4ea, replyNumber=0, likeNumber=84, createdTime=2019-09-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e171590e4ea, moduleTitle=JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e171590e4ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990645, encodeId=13531990645c7, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JCO：顺铂不能延长老年非小细胞肺癌患者总生存, objectType=article, longId=144994, objectId=8a2914499419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a2914499419, replyNumber=0, likeNumber=69, createdTime=2019-04-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a2914499419, moduleTitle=JCO：顺铂不能延长老年非小细胞肺癌患者总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a2914499419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990649, encodeId=3d5719906490c, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Thorax：非小细胞肺癌患者年龄、贫困和特定合并症与接受大手术的关联, objectType=article, longId=146683, objectId=1382146683ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1382146683ba, replyNumber=0, likeNumber=55, createdTime=2018-12-16, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1382146683ba, moduleTitle=Thorax：非小细胞肺癌患者年龄、贫困和特定合并症与接受大手术的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1382146683ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺癌患者

2020-05-29

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet Oncol：满足 vs 不满足USPSTF筛查标准的肺癌患者，5年生存率相似

2020-03-18

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后

2019-09-02

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

PLos One：肺癌患者肺泡巨噬细胞中NLRP3/Caspase-1炎症小体的激活降低

2019-09-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

MYSTIC研究：durvalumab与tremelimumab联用无法显著提高肺癌患者的生存率

2019-06-14

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

英国NICE推荐将辉瑞的Vizimpro用于治疗EGFR阳性的非小细胞肺癌患者

2019-12-03

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

AACR：PD-1单抗keytruda在晚期小细胞肺癌患者中显示出抗肿瘤潜力

2019-08-06

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet Oncol：Nivolumab治疗与晚期非小细胞肺癌患者4年生存期

2020-03-05

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

ANN ONCOL：ALK FISH阳性率与ALK阳性非小细胞肺癌患者接受克唑替尼治疗有效性之间的关系

2018-12-03

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理

2019-12-20

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

真实世界数据：支持阿法替尼用于老年晚期肺癌患者

2019-04-15

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Chest：肺癌患者的咳嗽：特征和临床关联的纵向观察性研究

2019-02-03

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

创新靶向药医保报销落地晚期肺癌患者的福音？

2019-03-15

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Thorax：不能手术肺癌患者的多学科家庭康复治疗

2019-09-01

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

肺癌患者半年后PET/CT复查，发现……

2019-06-28

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

PLos One：老年肺癌患者生存率预测G8筛查工具的前瞻性评估

2019-06-08

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JTO：淋巴细胞浸润、PD-L1、吸烟史之间是何种微妙关系，它们如何影响未曾接受免疫抑制剂治疗的非小细胞肺癌患者的预后？

2019-07-13

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Eur Respir J：晚期非小细胞肺癌患者培美曲塞维持治疗期间的肾功能损害

2019-10-09

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素

2019-09-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JCO：顺铂不能延长老年非小细胞肺癌患者总生存

2019-04-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Thorax：非小细胞肺癌患者年龄、贫困和特定合并症与接受大手术的关联

2018-12-16

科室
- - 订阅+
  - 更多科室
工具
服务